drugset / Trial / NCT00642239

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

NCT00642239 ↗

Phase 4 Unknown 48 enrolled Shandong Luye Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This multicentered clinical trial is going to find out the radio-sensitization action of sodium glycididazole in radiochemotherapy for esophageal cancer.

Timeline

Start
2008-04
Primary completion
2008-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Glycididazole Small molecule 700 mg/m2 Intravenous